Skip to main content

Articles

Page 70 of 84

  1. Expansion protocols aim at both increasing the number of umbilical cord blood (UCB) hematopoietic stem cells and progenitor cells (HSPCs) and reducing the period of neutropenia in UCB HSPC graft. Because glyco...

    Authors: Lionel Faivre, Véronique Parietti, Fernando Siñeriz, Sandrine Chantepie, Marie Gilbert-Sirieix, Patricia Albanese, Jérôme Larghero and Valérie Vanneaux
    Citation: Stem Cell Research & Therapy 2016 7:3
  2. Many retinal degenerative diseases are caused by the loss of retinal ganglion cells (RGCs). Autosomal dominant optic atrophy is the most common hereditary optic atrophy disease and is characterized by central ...

    Authors: Jing Chen, Hamidreza Riazifar, Min-Xin Guan and Taosheng Huang
    Citation: Stem Cell Research & Therapy 2016 7:2
  3. Multiple sclerosis is a demyelinating disease mostly of autoimmune origin that affects and damages the central nervous system, leading to a disabling condition. The aim of the present study was to investigate ...

    Authors: Oriana Trubiani, Sabrina Giacoppo, Patrizia Ballerini, Francesca Diomede, Adriano Piattelli, Placido Bramanti and Emanuela Mazzon
    Citation: Stem Cell Research & Therapy 2016 7:1
  4. The use of mesenchymal stem cells (MSCs) to treat inflammatory bowel disease (IBD) is of great interest because of their immunomodulatory properties. Damage to the enteric nervous system (ENS) is implicated in...

    Authors: Rhian Stavely, Ainsley M. Robinson, Sarah Miller, Richard Boyd, Samy Sakkal and Kulmira Nurgali
    Citation: Stem Cell Research & Therapy 2015 6:263
  5. Although metformin, a first-line drug for treating diabetes, may play an important role in inhibition of epithelial ovarian cancer cell growth and cancer stem cells (CSCs), metformin at low dose showed less ef...

    Authors: Rongrong Zhang, Ping Zhang, Hong Wang, Dongming Hou, Wentao Li, Guishan Xiao and Chenwei Li
    Citation: Stem Cell Research & Therapy 2015 6:262
  6. Heterogeneity of endothelial cells (ECs) is a hallmark of the vascular system which may impact the development and management of vascular disorders. Despite the tremendous progress in differentiation of human ...

    Authors: Gopu Sriram, Jia Yong Tan, Intekhab Islam, Abdul Jalil Rufaihah and Tong Cao
    Citation: Stem Cell Research & Therapy 2015 6:261
  7. Due to their intrinsic properties, stem cells are promising tools for new developments in tissue engineering and particularly for cartilage tissue regeneration. Although mesenchymal stromal/stem cells from bon...

    Authors: Loïc Reppel, Jessica Schiavi, Naceur Charif, Léonore Leger, Hao Yu, Astrid Pinzano, Christel Henrionnet, Jean-François Stoltz, Danièle Bensoussan and Céline Huselstein
    Citation: Stem Cell Research & Therapy 2015 6:260
  8. Recent evidence has demonstrated that cardiac progenitor cells play an essential role in the induction of angiomyogenesis in infarcted myocardium. We and others have shown that engraftment of c-kit+ cardiac stem ...

    Authors: Yu Tina Zhao, Jianfeng Du, Youfang Chen, Yaoliang Tang, Gangjian Qin, Guorong Lv, Shougang Zhuang and Ting C. Zhao
    Citation: Stem Cell Research & Therapy 2015 6:259
  9. Adult mesenchymal stem cells (MSCs) are considered promising candidates for cell-based therapies. Their potential utility derives primarily from their immunomodulatory activity, multi-lineage differentiation p...

    Authors: Catherine M. Kolf, Lin Song, Jeannine Helm and Rocky S. Tuan
    Citation: Stem Cell Research & Therapy 2015 6:258
  10. Stem cell treatment provides a promising therapy for patients with spinal cord injury (SCI). However, the applied stem cells exert their effects in different manners that are dependent on the route used for ad...

    Authors: Takashi Amemori, Jiri Ruzicka, Nataliya Romanyuk, Meena Jhanwar-Uniyal, Eva Sykova and Pavla Jendelova
    Citation: Stem Cell Research & Therapy 2015 6:257
  11. Promotion of bone regeneration is important for successful repair of bony defects. This study aimed to investigate whether combining bone marrow-derived mesenchymal stem cell (BMSC) sheets with platelet-rich p...

    Authors: Yiying Qi, Lie Niu, Tengfei Zhao, Zhongli Shi, Tuoyu Di, Gang Feng, Junhua Li and Zhongming Huang
    Citation: Stem Cell Research & Therapy 2015 6:256
  12. Mesenchymal stem cells (MSCs) harvested from cadaveric tissues represent a promising approach for regenerative medicine. To date, no study has investigated whether viable MSCs could survive in cadaveric tissue...

    Authors: Mohamad Khir Shikh Alsook, Annick Gabriel, Joëlle Piret, Olivier Waroux, Céline Tonus, Delphine Connan, Etienne Baise and Nadine Antoine
    Citation: Stem Cell Research & Therapy 2015 6:253
  13. Molecular imaging is one of the methods to follow-up stem cell therapy by visualization in the brain. In a recent article in Stem Cell Research & Therapy, Micci et al. offer a thorough discussion of the advantage...

    Authors: Nora Sandu, Tumul Chowdhury and Bernhard Schaller
    Citation: Stem Cell Research & Therapy 2015 6:252
  14. Adult skeletal stem cells (SSCs) often exhibit limited in vitro expansion with undesirable phenotypic changes and loss of differentiation capacity. Foetal tissues offer an alternative cell source, providing SSCs ...

    Authors: David Gothard, Kelvin Cheung, Janos M. Kanczler, David I. Wilson and Richard O. C. Oreffo
    Citation: Stem Cell Research & Therapy 2015 6:251
  15. Mesenchymal stem cells (MSCs) stabilise endothelial barrier function in acute lung injury via paracrine hepatocyte growth factor (HGF). Vascular endothelial growth factor (VEGF), which is secreted by MSCs, is ...

    Authors: Yi Yang, Qi-hong Chen, Ai-ran Liu, Xiu-ping Xu, Ji-bin Han and Hai-bo Qiu
    Citation: Stem Cell Research & Therapy 2015 6:250
  16. Periodontitis is one of the most widespread infectious diseases in humans. We previously promoted significant periodontal tissue regeneration in swine models with the transplantation of autologous periodontal ...

    Authors: Yu Cao, Zhenhai Liu, Yilin Xie, Jingchao Hu, Hua Wang, Zhipeng Fan, Chunmei Zhang, Jingsong Wang, Chu-Tse Wu and Songlin Wang
    Citation: Stem Cell Research & Therapy 2015 6:249
  17. Mesenchymal stem cells (MSCs) have been widely applied to treat various inflammatory diseases. Inflammatory cytokines can induce both apoptosis and autophagy in MSCs. However, whether autophagy plays a pro- or...

    Authors: Shipeng Dang, Zhi-ming Yu, Chang-ying Zhang, Jie Zheng, Ku-lin Li, Ying Wu, Ling-ling Qian, Zhen-yu Yang, Xiao-rong Li, Yanyun Zhang and Ru-xing Wang
    Citation: Stem Cell Research & Therapy 2015 6:247
  18. Huntington’s disease (HD) is an inherited disease that causes progressive nerve cell degeneration. It is triggered by a mutation in the HTT gene that strongly influences functional abilities and usually results i...

    Authors: Irina Kerkis, Monica Santoro Haddad, Cristiane Wenceslau Valverde and Sabina Glosman
    Citation: Stem Cell Research & Therapy 2015 6:232
  19. Hepatic cell therapy has become a viable alternative to liver transplantation for life-threatening liver diseases. However, the supply of human hepatocytes is limited due to the shortage of suitable donor orga...

    Authors: Laia Tolosa, Jérôme Caron, Zara Hannoun, Marc Antoni, Silvia López, Deborah Burks, Jose Vicente Castell, Anne Weber, Maria-Jose Gomez-Lechon and Anne Dubart-Kupperschmitt
    Citation: Stem Cell Research & Therapy 2015 6:246
  20. Systemic delivery of bone marrow-derived mesenchymal stem cells (MSC) seems to be of benefit in the treatment of multiple sclerosis (MS), an autoimmune disease of the central nervous system (CNS) sustained by ...

    Authors: Federica Benvenuto, Adriana Voci, Enrico Carminati, Francesca Gualandi, Gianluigi Mancardi, Antonio Uccelli and Laura Vergani
    Citation: Stem Cell Research & Therapy 2015 6:245
  21. Mesenchymal stem cells (MSCs) have been identified as a viable treatment for inflammatory bowel disease (IBD). MSCs derived from bone marrow (BM-MSCs) have predominated in experimental models whereas the major...

    Authors: Rhian Stavely, Ainsley M. Robinson, Sarah Miller, Richard Boyd, Samy Sakkal and Kulmira Nurgali
    Citation: Stem Cell Research & Therapy 2015 6:244
  22. For expansion of human mesenchymal stem cells (MSCs), autologous human serum is safer than fetal bovine serum in clinical situations. One of the problems with the use of autologous human serum is that its prol...

    Authors: Mitsuru Mizuno, Hisako Katano, Koji Otabe, Keiichiro Komori, Yukie Matsumoto, Shizuka Fujii, Nobutake Ozeki, Kunikazu Tsuji, Hideyuki Koga, Takeshi Muneta, Akifumi Matsuyama and Ichiro Sekiya
    Citation: Stem Cell Research & Therapy 2015 6:243
  23. Human mesenchymal stem cells (MSCs) are multipotent cells that can differentiate into fat, muscle, bone and cartilage cells. Exposure of subcutaneous abdominal adipose tissue derived AD-MSCs to high glucose (H...

    Authors: Sabyasachi Sen, Cleyton C. Domingues, Carol Rouphael, Cyril Chou, Chul Kim and Nagendra Yadava
    Citation: Stem Cell Research & Therapy 2015 6:242
  24. The use of stem cells from adipose tissue or adipose-derived stem cells (ASCs) in regenerative medicine could be an interesting alternative to bone marrow stem cells because they are easily accessible and avai...

    Authors: Jonathan Rodriguez, Fabien Boucher, Charlotte Lequeux, Audrey Josset-Lamaugarny, Ondine Rouyer, Orianne Ardisson, Héléna Rutschi, Dominique Sigaudo-Roussel, Odile Damour and Ali Mojallal
    Citation: Stem Cell Research & Therapy 2015 6:241
  25. Treating a myocardial infarction (MI), the most frequent cause of death worldwide, remains one of the most exciting medical challenges in the 21st century. Cardiac tissue engineering, a novel emerging treatmen...

    Authors: Isaac Perea-Gil, Cristina Prat-Vidal and Antoni Bayes-Genis
    Citation: Stem Cell Research & Therapy 2015 6:248
  26. Pathophysiological changes associated with chronic kidney disease impair angiogenic processes and increase renal fibrosis. Progenitor-like cells derived from adult kidney have been previously used to promote r...

    Authors: CL Chen, KJ Chou, HC Fang, CY Hsu, WC Huang, CW Huang, CK Huang, HY Chen and PT Lee
    Citation: Stem Cell Research & Therapy 2015 6:239
  27. Extracellular vesicles (EVs) are a heterogeneous population of naturally occurring secreted small vesicles, with distinct biophysical properties and different functions both in physiology and under pathologica...

    Authors: Almudena Fuster-Matanzo, Florian Gessler, Tommaso Leonardi, Nunzio Iraci and Stefano Pluchino
    Citation: Stem Cell Research & Therapy 2015 6:227
  28. Stem cells are considered an important resource for tissue repair and regeneration. Their utilization in regenerative medicine will be aided by mechanistic insight into their responsiveness to external stimuli...

    Authors: Natasha Baker, Jihee Sohn and Rocky S. Tuan
    Citation: Stem Cell Research & Therapy 2015 6:238
  29. Mesenchymal stem/stromal cells (MSCs) improve the metabolic function of co-cultured hepatocytes. The present study aimed to further enhance the trophic effects of co-culture with hepatocytes using hypoxic prec...

    Authors: Harry H. Qin, Céline Filippi, Song Sun, Sharon Lehec, Anil Dhawan and Robin D. Hughes
    Citation: Stem Cell Research & Therapy 2015 6:237
  30. The inherent immunomodulatory capacity of mesenchymal stem/progenitor cells (MSPCs) encouraged initiation of multiple clinical trials. Release criteria for therapeutic MSPCs cover identity, purity and safety b...

    Authors: Nina Ketterl, Gabriele Brachtl, Cornelia Schuh, Karen Bieback, Katharina Schallmoser, Andreas Reinisch and Dirk Strunk
    Citation: Stem Cell Research & Therapy 2015 6:236
  31. Bone marrow-derived mesenchymal stem cells (BM-MSCs) for clinical use should not be grown in media containing fetal bovine serum (FBS), because of serum-related concerns over biosafety and batch-to-batch varia...

    Authors: Rubie Rakian, Travis J. Block, Shannan M. Johnson, Milos Marinkovic, Junjie Wu, Qiuxia Dai, David D. Dean and Xiao-Dong Chen
    Citation: Stem Cell Research & Therapy 2015 6:235
  32. Mesenchymal stem cells (MSCs) are ideal for cell-based therapy in various inflammatory diseases because of their immunosuppressive and tissue repair properties. Moreover, their immunosuppressive properties and...

    Authors: Jun Zhang, Xiaowen Huang, Haijun Wang, Xiaoyan Liu, Tao Zhang, Yunchuan Wang and Dahai Hu
    Citation: Stem Cell Research & Therapy 2015 6:234
  33. Equine superficial digital flexor tendon injury is a well-accepted model of human tendon injury and is routinely treated with local injections of autologous mesenchymal stem cells (MSCs). Identification of a c...

    Authors: Alexis Mitchell, Kristen A. Rivas, Roger Smith III and Ashlee E. Watts
    Citation: Stem Cell Research & Therapy 2015 6:231
  34. Endothelial progenitor cells (EPCs) improve survival and reduce organ failure in cecal ligation and puncture-induced sepsis; however, expanded EPCs may represent an even better approach for vascular repair. To...

    Authors: Andreas Güldner, Tatiana Maron-Gutierrez, Soraia Carvalho Abreu, Debora Gonçalves Xisto, Alexandra Cristina Senegaglia, Patty Rose da Silva Barcelos, Johnatas Dutra Silva, Paulo Brofman, Marcelo Gama de Abreu and Patricia Rieken Macedo Rocco
    Citation: Stem Cell Research & Therapy 2015 6:230
  35. Mesenchymal stem cells can potentially be used in therapy for spinal cord injury (SCI). Methylprednisolone sodium succinate (MPSS) has been used as a scavenging agent in acute SCI treatment, but its use no lon...

    Authors: Yongsun Kim, Sung-ho Jo, Wan Hee Kim and Oh-Kyeong Kweon
    Citation: Stem Cell Research & Therapy 2015 6:229
  36. Although mesenchymal stem cells (MSCs) from different sources share many similar characteristics, they also exhibit individual properties. In this study, we compared MSCs derived from Wharton’s jelly in the um...

    Authors: Gecai Chen, Aihuan Yue, Zhongbao Ruan, Yigang Yin, Ruzhu Wang, Yin Ren and Li Zhu
    Citation: Stem Cell Research & Therapy 2015 6:228
  37. Human mesenchymal stem cells (hMSCs) have been approved for therapeutic applications. Despite the advances in this field, in vitro approaches are still required to improve the essential indices that would pave...

    Authors: Maryam Hafizi, Atena Hajarizadeh, Amir Atashi, Somayeh Kalanaky, Saideh Fakharzadeh, Zahra Masoumi, Mohammad Hassan Nazaran and Masoud Soleimani
    Citation: Stem Cell Research & Therapy 2015 6:226
  38. Human mesenchymal stem cells (hMSCs), also called mesenchymal stromal cells, have been of great interest in regenerative medicine applications because of not only their differentiation potential but also their...

    Authors: Krishna M. Panchalingam, Sunghoon Jung, Lawrence Rosenberg and Leo A. Behie
    Citation: Stem Cell Research & Therapy 2015 6:225
  39. In previous study the streptavidin interleukin-2 (SA-IL-2)-modified MB49 vaccine was effective against bladder cancer in a mouse model. However, a small portion of tumors regrew because the vaccine could not e...

    Authors: Yong-tong Zhu, Shi-yu Pang, Cheng-yong Lei, Yang Luo, Qing-jun Chu and Wan-long Tan
    Citation: Stem Cell Research & Therapy 2015 6:224
  40. Human induced pluripotent stem cells (hiPSCs) are considered as one of the most promising seed cell sources in regenerative medicine. Now hiPSC-based clinical trials are underway. To ensure clinical safety, ce...

    Authors: Juan Wang, Jie Hao, Donghui Bai, Qi Gu, Weifang Han, Lei Wang, Yuanqing Tan, Xia Li, Ke Xue, Pencheng Han, Zhengxin Liu, Yundan Jia, Jun Wu, Lei Liu, Liu Wang, Wei Li…
    Citation: Stem Cell Research & Therapy 2015 6:223
  41. Mesenchymal stem (stromal) cells (MSCs) possess self-renewal, differentiation and immunoregulatory properties, and therefore are being evaluated as cellular therapy for inflammatory and autoimmune diseases, an...

    Authors: Mahesh Khatri, Timothy D. O’Brien, Kuldeep S. Chattha and Linda J. Saif
    Citation: Stem Cell Research & Therapy 2015 6:222
  42. This study was aimed at deciphering the secretome of adipose-derived mesenchymal stromal cells (ADSCs) cultured in standard and hypoxic conditions to reveal proteins, which may be responsible for regenerative ...

    Authors: Natalia Kalinina, Daria Kharlampieva, Marina Loguinova, Ivan Butenko, Olga Pobeguts, Anastasia Efimenko, Luidmila Ageeva, George Sharonov, Dmitry Ischenko, Dmitry Alekseev, Olga Grigorieva, Veronika Sysoeva, Ksenia Rubina, Vassiliy Lazarev and Vadim Govorun
    Citation: Stem Cell Research & Therapy 2015 6:221
  43. Spinal V3 interneurons (INs) are a commissural, glutamatergic, propriospinal neuron population that holds great potential for understanding locomotion circuitry and local rewiring after spinal cord injury. Emb...

    Authors: Hao Xu, Nisha Iyer, James E. Huettner and Shelly E. Sakiyama-Elbert
    Citation: Stem Cell Research & Therapy 2015 6:220
  44. Degenerative retinal diseases like age-related macular degeneration (AMD) are the leading cause of blindness. Cell transplantation showed promising therapeutic effect for such diseases, and embryonic stem cell...

    Authors: Zepeng Qu, Yuan Guan, Lu Cui, Jian Song, Junjie Gu, Hanzhi Zhao, Lei Xu, Lixia Lu, Ying Jin and Guo-Tong Xu
    Citation: Stem Cell Research & Therapy 2015 6:219

Annual Journal Metrics

  • 2022 Citation Impact
    7.5 - 2-year Impact Factor
    8.0 - 5-year Impact Factor
    1.440 - SNIP (Source Normalized Impact per Paper)
    1.498 - SJR (SCImago Journal Rank)

    2023 Speed
    33 days submission to first editorial decision for all manuscripts (Median)
    211 days submission to accept (Median)

    2023 Usage 
    3,320,811 downloads
    1,402 Altmetric mentions